We report on the development and testing of a novel, rapid, colorimetric immunodiagnostic kit, Cholera SMART, for direct detection of the presence of Vibrio cholerae 01 in clinical specimens. Unlike conventional culture methods requiring several days to complete, the Cholera SMART kit can be used directly in the field by untrained or minimally skilled personnel to detect V. cholerae 01 in less than 15 (9) .
Columbia, Md.). The CholeraScreen test employs a monoclonal antibody, COLTA (University of Maryland Biotechnology Institute, College Park, Md.), specific to the A factor of V. cholerae 01 lipopolysaccharide. This monoclonal antibody has been found to be highly specific for V. cholerae 01 when tested by the indirect fluorescent-antibody method (2, 6) .
Reported here are the development and testing of a colloidal-gold-based, colorimetric immunoassay employing NHD Sensitive Membrane Antigen Rapid Test (SMART) technology for direct detection of the presence of V. cholerae 01 in clinical specimens. The COLTA monoclonal antibody (6) and a high-titer polyclonal anti-V. cholerae 01 antibody (1) have been incorporated into the SMART kit to produce a novel, rapid, simple method for detection of V. cholerae 01. The principle of the test is as follows. A specimen suspected of containing V. cholerae 01 is reacted to a colloidal-gold-labeled monoclonal antibody, COLTA (University of Maryland Biotechnology Institute). If V. cholerae 01 antigen is present in a specimen, it complexes to the anti-V. cholerae 01 monoclonal antibody and the complex diffuses and is subsequently captured and concentrated by a polyclonal-antibody-coated solid-phase matrix and appears to the naked eye as a pink-to-red test spot developing from the deposition of colloidal gold. In the absence of V. cholerae 01, a complex does not form and, hence, no pink-to-red color appears in the test spot (9) .
Development of the Cholera SMART kit. In the Cholera SMART format employed here, the antigens are bound within a monoclonal-polyclonal-antibody sandwich. In the development phase of the diagnostic Cholera SMART kit, other monoclonal antibodies, as well as other combinations of antibodies, were tested in the sandwich assay, including monoclonal-monoclonal-and polyclonal-polyclonal-antibody pairings. The combination presented in this study proved the most effective on the basis of sensitivity and specificity, as well as color intensity (9 (20) . The specificity and antibody activity in each preparation of anti-V. cholerae 01 serum were tested by both slide agglutination (1) and coagglutination (4) . The kit contains reconstitution buffer (0.01 M phosphate-buffered saline containing 3% Tween 20, pH 7.3), extraction buffer (0.05 M Tris, 0.05 M EDTA, 0.1 M NaCl, pH 8.2), and a specimen-filtering device consisting of a squeezable 2-ml plastic tube with a snap-on filter (1-,um pore size) that allows bacterial cells to pass through while retaining any particulates that could interfere with the reaction. In addition, swabs (100% Dacron) for reagent transfer or sampling are also provided in the kit.
Procedure. Specimens were treated in accordance with the instructions of the manufacturer (NHD). In brief, 2 drops of reconstitution buffer are added first into the reaction vial. Then 4 drops of a watery stool specimen are released through the filtering device, provided as part of the kit, into the reaction vial. If the stool specimen is not in liquid form (e.g., at least semisolid), it is treated with extraction buffer in the filtering device before 4 drops are released into the reaction vial. A sterile swab is inserted into the reaction vial to absorb the reconstituted contents. The swab is then placed in the upper compartment of the SMART device, after which the device is closed. The reactants diffuse from the swab through the membrane onto both the test and negative control spots in the lower compartment of the kit.
If V. cholerae 01 antigen is present, the antigen-antibody complex formed with colloidal gold is captured by the polyclonal anti-V. cholerae 01 antibody in the lower compartment. A red dot appears within 5 to 10 min, whereas the negative control spot remains unchanged, i.e., no color develops. If the antigen is absent or below the level of sensitivity of the test kit, the test spot does not develop any color visible to the naked eye. From start to finish, the test is performed in less than 15 min.
Specificity of Cholera SMART. The specificity of the kit was determined by using 120 pure cultures isolated from samples collected in several geographical regions of the world and from various sources. These bacterial strains were selected to represent the families of Vibrionaceae, Enterobactenaceae, and Aeromonadaceae (5). In brief, colonies of a pure culture grown on tryptic soy agar (Difco Laboratories, Detroit, Mich.) were suspended in sterile saline (0.15 M NaCl) to McFarland no. 1 standard (3 x 108 CFU/ml) (15) . Two drops of reconstitution buffer and 4 drops of culture fluid were added to the reaction vial. The test swab was inserted into the reaction vial and allowed to absorb the contents, after which the swab was placed in the SMART device as described above. (16) . Suspected colonies resembling V. cholerae, i.e., yellow colonies on thiosulfatecitrate-bile salts-sucrose agar and gelatinase-positive (halopositive) colonies from taurocholate-tellurate-gelatin agar, were tested by slide agglutination with V. cholerae 01 polyvalent antiserum prepared at the ICDDRB. The stool specimens were also tested directly with Cholera SMART and CholeraScreen (the latter is a coagglutination test described elsewhere [4] ) by following the manufacturer's (NHD) instructions.
(ii) Mexico. A second field trial was conducted at the Social Security Hospitals in Mexico City and Puebla, Mexico. Of the 108 stool specimens tested, 98 were swabs in Cary-Blair transport medium and 10 were freshly collected specimens. The swabs were treated with extraction buffer in the filtering device and tested directly with Cholera SMART and CholeraScreen.
When tested for specificity, Cholera SMART was positive only with strains of V. cholerae 01 (n = 30) and did not cross-react with any other bacterial species (n = 90), demonstrating 100% specificity (Table 1) . In Table 2 Forty-four stool specimens were tested in the field trial at the ICDDRB. Twenty-two (95.6%) of the 23 culture-positive (all were El Tor Ogawa) stool specimens were V. cholerae 01 positive by Cholera SMART, while the remaining 21 specimens were negative by both culture and Cholera SMART, yielding 100% specificity. The results showed that Cholera SMART detected V. cholerae 01 in all of the stool specimens that were culture positive, and none of the negative specimens tested positive (P < 10-8; chi-square test). Only one culture-positive, Cholera SMART-negative stool specimen was Cholera SMART positive when subsequently tested with the pure culture isolated from the same stool specimen, suggesting that the number of organisms in the original stool specimen was below the level of detection, i.e., <6 x 106 CFU/ml. Results obtained by Cholera SMART, when compared with those obtained by the culture method, were in agreement (100%) with results of the CholeraScreen (NHD) coagglutination test (4) . Of the 108 stool specimens tested in Mexico, 45 were positive by Table 2 .
Cholera SMART and also positive by CholeraScreen (NHD) while the remaining 63 samples were negative by both tests. The conventional culture method was not used for these samples. The Cholera SMART method offers simplicity and ease of use, minimal hands-on time, rapid turnaround time, unrefrigerated storage, no need for any additional equipment, and satisfactory deployment under field conditions. The test kit can be stored for up to a year at room temperature without loss of activity. Once the lyophilized colloidal-gold-labeled monoclonal antibody is reconstituted in the reaction vial, it should be used immediately to prevent any loss of activity.
SMART technology (NHD) has already been employed successfully to detect other pathogens, e.g., Neisseria gonorrhoeae (13) and Streptococcus pyogenes (11) (group A streptococci). The Cholera SMART test also has been introduced in the microbiology laboratory at the University of Maryland as a routine identification procedure and has proven to be effective when compared with labor-intensive biochemical tests. The recent epidemics of cholera in Central and South America emphasize the need for a rapid, simple, and reliable means of detecting V. cholerae 01 for diagnostic purposes, i.e., food and water quality assurance and environmental monitoring, as well as testing of clinical specimens (4, 14) . Cholera SMART, a significant development in methodology for rapid detection of V. cholerae 01, appears to satisfy this need (8, 9, 22) . Unlike conventional culture methods, which take several days to complete, Cholera SMART can detect the presence of V. cholerae 01 directly and reliably within minutes in clinical specimens, on site and without cumbersome laboratory equipment and/or trained personnel.
We conclude that Cholera SMART offers a rapid, simple, and reliable alternative to methods currently employed in microbiology laboratories and can be used as a diagnostic tool on site in the field in all areas of the world where cholera is epidemic.
